We are live on ! Find out more
DC

Defender Capital Portfolio holdings

AUM $308M
1-Year Est. Return 4.52%
This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+4.52%
3 Year Est. Return
+83.48%
5 Year Est. Return
+78.82%
10 Year Est. Return
–
AUM
$124M
AUM Growth
-$1.43M
Cap. Flow
-$2.42M
Cap. Flow %
-1.96%
Top 10 Hldgs %
97.22%
Holding
16
New
–
Increased
5
Reduced
9
Closed
–

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$2.23M
2
ENOV icon
Enovis
ENOV
+$464K
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$112K
4
CSCO icon
Cisco
CSCO
+$20.5K
5
WINA icon
Winmark
WINA
+$9.31K

Top Sells

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$1.97M
2
DHR icon
Danaher
DHR
+$1.36M
3
FTV icon
Fortive
FTV
+$791K
4
KMI icon
Kinder Morgan
KMI
+$584K
5
SER icon
Serina Therapeutics
SER
+$212K

Sector Composition

Rank Sector Weight
1 Healthcare 42.87%
2 Financials 22.95%
3 Consumer Staples 14.98%
4 Technology 13.9%
5 Consumer Discretionary 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.06T
$28.4M 22.95%
133,302
+540
+0.4% +$112K
DHR icon
2
Danaher
DHR
$142B
$21.2M 17.17%
167,977
-11,523
-6% -$1.36M
MNST icon
3
Monster Beverage
MNST
$93.4B
$18.5M 14.98%
579,090
-65,400
-10% -$1.97M
STAA icon
4
STAAR Surgical
STAA
$1.19B
$18.1M 14.62%
601,828
+77,142
+15% +$2.23M
FTV icon
5
Fortive
FTV
$18.6B
$16.4M 13.31%
321,319
-15,237
-5% -$791K
ENOV icon
6
Enovis
ENOV
$1.54B
$5.39M 4.36%
114,802
+9,645
+9% +$464K
LCTX icon
7
Lineage Cell Therapeutics
LCTX
$274M
$4.27M 3.45%
4,119,800
-94,760
-2% -$109K
WINA icon
8
Winmark
WINA
$1.37B
$3.5M 2.83%
20,078
+52
+0.3% +$9.31K
KMI icon
9
Kinder Morgan
KMI
$72.5B
$2.48M 2.01%
120,831
-28,958
-19% -$584K
INO icon
10
Inovio Pharmaceuticals
INO
$89.7M
$1.92M 1.55%
54,067
-3,633
-6% -$144K
CGEN icon
11
Compugen
CGEN
$221M
$1.19M 0.96%
306,733
-4,600
-1% -$16.3K
SER icon
12
Serina Therapeutics
SER
$32.7M
$938K 0.76%
7,474
-1,568
-17% -$212K
AMZN icon
13
Amazon
AMZN
$2.69T
$493K 0.4%
5,180
– –
AAPL icon
14
Apple
AAPL
$4.8T
$468K 0.38%
9,360
-1,216
-11% -$59.3K
CSCO icon
15
Cisco
CSCO
$436B
$263K 0.21%
4,722
+372
+9% +$20.5K
FIT
16
DELISTED
Fitbit, Inc. Class A common stock
FIT
$87K 0.07%
20,000
– –

Similar funds

PC
Pecaut & Co Sioux City, Iowa $308M AUM 15.9% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
AC
Alfreton Capital Radlett, Hertfordshire, United Kingdom $308M AUM 10.23% 1-Year Est. Return
EWM
Elite Wealth Management Kirkland, Washington $308M AUM 30.88% 1-Year Est. Return
ICP
Islander Capital Partners San Francisco, California $308M AUM
ACM
Argyle Capital Management Center Valley, Pennsylvania $308M AUM 24.01% 1-Year Est. Return
GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return
BBWA
Bell & Brown Wealth Advisors Newport Beach, California $308M AUM 36.32% 1-Year Est. Return

Defender Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Defender Capital held 16 positions worth $124M, down 1.1% from $125M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 0%. Defender Capital opened no new positions and made no exits, leaving the 16-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Financials and Consumer Staples.

  • Defender Capital added most to STAAR Surgical in Q2 2019, an estimated $2.23M increase.
  • Defender Capital's biggest Q2 2019 reduction was Monster Beverage, cutting an estimated $1.97M.
  • Defender Capital's ten largest holdings make up 97% of its $124M portfolio in Q2 2019.
  • Defender Capital opened 0 new positions and closed 0 in Q2 2019.
  • Defender Capital's portfolio value fell 1.1% quarter-over-quarter to $124M.

Based on Defender Capital's 13F filing for Q2 2019, filed 20 Aug 2019.